Volume : 08, Issue : 11, November – 2021



Authors :

Fatima Unnisa, Niyati Kandikanti, Kadam Sushmitha, Parsanaboina Sridivya, Syed Alamdar Shariyar

Abstract :

Background: Chronic Kidney Disease (CKD) is a serious medical and public health problem whose prevalence is increasing worldwide. CKD patients are medically complex, require multiple medications for treatments of their various comorbidities, thus these patients are at risk of drug-related problems (DRPs) that may lead to increased morbidity, mortality, and cost to the healthcare system. Methodology: This study was a Prospective, Observational Study carried out for a period of six months in tertiary care hospital to assess the impact of medication counselling on the KDQOL of chronic kidney patients. A total of 32 patients undergoing hemodialysis were enrolled into the study who were categorized into test and control groups by randomize method. Patients in the test group received counselling verbally along with the information leaflet, whereas the control group received the counselling only after the end of the study. The QoL of patients were assessed by using Kidney Disease Quality of Life-36 (KDQOL-36) questionnaire at the baseline and at final follow-up. Result: A statistically significant difference in the domain 4(p< 0.00015)) and domain 5(p<0.000278) was found at 2nd follow up period in test group and in contrast, no significant improvement in control group. The impact of pharmacist’s medication counselling on QOL in hemodialysis patients had showed significant improvement.in test group compare to control group. Conclusion: The study suggests that the periodic counselling by a clinical pharmacist at regular intervals has a positive impact on improving the QOL of hemodialysis patients.
Keywords: Chronic Kidney Disease, Medication Counselling, KDQOL

Cite This Article:

Please cite this article in press FatimaUnnisa et al, Assessment Of The Impact Of Medication Counselling On KDQOL Score Of Patients With Chronic Kidney Diseases., Indo Am. J. P. Sci, 2021; 08(11).

Number of Downloads : 10


1. Sharma S, Shobha Rani RH, Subramanian G, Irma M. Evaluation of impact of counseling on quality of life of chronic kidney disease and Hemodialysis patients. IJOPP. 2013;6(3):57–61.
2. Luyckx V, Tonelli M, Stanifer J. The global burden of kidney disease and the sustainable development goals. Bulletin of the World Health Organization. 2018;96(6):414-422D.
3. Mateti UV, Nagappa AN, Attur RP, Nagarapu SP, Rangaswamy D. Impact of pharmaceutical care on the health-related quality of life among hemodialysis patients – A multicentre randomized controlled study. Saudi J Kidney Dis Transpl. 2017;28(6):1293-1306. doi:10.4103/1319-2442.220879.
4. Wang WL, Liang S, Zhu FL, et al. The prevalence of depression and the association between depression and kidney function and health-related quality of life in elderly patients with chronic kidney disease: a multicentre cross-sectional study. Clin Interv Aging. 2019; 14:905-913. Published 2019 May 15. doi:10.2147/CIA.S203186
5. Wagner E, Austin B, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving Chronic Illness Care: Translating Evidence into Action. Health Affairs [Internet]. 2001;20(6):64-78. Available from: http://doi: 10.1377/hlthaff.20.6.64
6. Danguilan R, Cabanayan-Casasola C, Evangelista N, Pelobello M, Equipado C, Lucio-Tong M et al. An education and counseling program for chronic kidney disease: strategies to improve patient knowledge. Kidney International Supplements [Internet]. 2013;3(2):215-218. Available from: https://doi.org/10.1038/kisup.2013.17
7. Shareef J, Kripa GS, Baikunje S. Impact of Pharmacists’ Counseling on Quality of Life in Patients Undergoing Hemodialysis in a Tertiary Care Teaching Hospital. World J Nephrol Urol. 2014;3(4):143–50.
8. Thomas D, Joseph J, Francis B, et al. Effect of patient counseling on quality of life of hemodialysis patients in India. Pharm Pract. 2009;7(3): 181-184
9. Khokhar A, Khan YH, MallhiTH, et al. Effectiveness of pharmacist intervention model for chronic kidney disease patients; a prospective comparative study. Int J Clin Pharm.2020; 42: 625–634.
10. Rodrigues pa, saji a, raj p, sony s. Impact of pharmacist intervention on medication knowledge and adherence in hemodialysis patients. Int j pharm pharm sci [internet]. 2019;11(7):131-3. Doi:10.22159/ijpps.2019v11i7.31305
11. Bakarman MA, Felimban MK, Atta MM, Butt NS. The effect of an educational program on quality of life in patients undergoing hemodialysis in western Saudi Arabia. Saudi Med J. 2019;40(1):66-71. doi: 10.15537/smj.2019.1.23401
12. Balasubramanian T, Nathaliya PM, Nayana SA, et al. Effect of patient counseling on health-related quality of life among end stage renal disease patients undergoing hemodialysis. Asian J. Pharm. Sci.2017;7(3):1730-1733.
13. Dashti-Khavidaki S, Sharif Z, Khalili H, et al. The use of pharmaceutical care to improve health-related quality of life in hemodialysis patients in Iran. Int J Clin Pharm. 2013;35(2):260-267. doi:10.1007/s11096-012-9748-6
14. Ghimirey A, Sapkota B, Shrestha S, Basnet N, Shankar PR, Sapkota S. Evaluation of pharmacist counseling in improving knowledge, attitude, and practice in chronic kidney disease patients. SAGE Open Med. 2013; 1:2050312113516111.
doi: 10.1177/2050312113516111
15. Rani NV, Soundararajan P, Samyuktha CHL, Kannan G, Thennarasu P. Impact of clinical pharmacist provided education on medication knowledge and adherence of hemodialysis patients in a South Indian University Hospital. Asian J Pharm Clin Res. 2013;6(4):24–27.
16. Abraham S, Venu A, Ramachandran A, Chandran PM, Raman S. Assessment of quality of life in patients on hemodialysis and the impact of counseling. Saudi J Kidney Dis Transpl.2012;23(5):953-957
17. Parthasarathi G, Sathvik B, Mangasuli S, Narahari M, Gurudev K. Medication knowledge of hemodialysis patients and influence of clinical pharmacists provided education on their knowledge. Indian Journal of Pharmaceutical Sciences. 2007;69(2):232.